Monsenso A/S (CPH:MONSO)

Market Cap	14.79M
Revenue (ttm)	11.17M
Net Income (ttm)	-6.00M
Shares Out	66.64M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,853
Average Volume	25,952
Open	0.2320
Previous Close	0.2220
Day's Range	0.2320 - 0.2320
52-Week Range	0.2080 - 0.9500
Beta	1.97
RSI	41.78
Earnings Date	Mar 7, 2025

About Monsenso

Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes. It also provides Monsenso solution, a software as a medical device for mental health professionals application that has data collection, direct messaging, visualization and feedback, psy...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2013
• Employees: 13
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: MONSO

Financial Performance

In 2024, Monsenso's revenue was 11.17 million, an increase of 16.01% compared to the previous year's 9.62 million. Losses were -6.00 million, 12.0% more than in 2023.